Blood sugar does shift across the menstrual cycle, and the pattern is consistent enough that researchers can track it with continuous glucose monitors. In women without diabetes, glucose tends to be lowest around ovulation and highest in the week or so before a period, during the luteal phase. The difference is modest in healthy individuals but becomes clinically meaningful for people managing type 1 diabetes. The hormones driving these shifts, primarily estrogen and progesterone, push insulin sensitivity in opposite directions at different points in the cycle.
The Glucose Pattern Across the Cycle
A continuous glucose monitoring study that tracked women across full menstrual cycles found a clear biphasic pattern. Glucose levels were lowest during the late-follicular phase, around day 13 or 14 of the cycle, then gradually climbed through ovulation and peaked during the luteal phase before dropping sharply once menstruation began.1PubMed Central. Blood glucose variance measured by continuous glucose monitors across the menstrual cycle The difference between the low point and the peak was small in absolute terms, but it was statistically significant and persisted even after the researchers adjusted for age, body weight, and self-reported menstrual symptoms like food cravings and fatigue.
That last point matters because it suggests the glucose shift is not just a side effect of eating differently before your period. The hormonal changes themselves are doing something to how your body handles sugar, independent of whether you are reaching for more snacks in the premenstrual window.
How Estrogen and Progesterone Pull in Opposite Directions
The reason glucose tracks the menstrual cycle comes down to two hormones doing opposite things to insulin sensitivity. Estrogen, which peaks around ovulation and in the first half of the cycle, helps your body respond to insulin more effectively. In animal studies, estrogen reduced blood glucose levels by suppressing the liver’s production of new glucose and improving the uptake of sugar from the blood.2PubMed Central. Estrogen Improves Insulin Sensitivity and Suppresses Gluconeogenesis via the Transcription Factor Foxo1 This is consistent with the observation that blood sugar tends to be at its lowest when estrogen is high.
Progesterone, which dominates the luteal phase, works in the other direction. Laboratory research has shown that progesterone interferes with the signaling chain that insulin uses to move glucose into cells.3PubMed. Progesterone inhibits glucose uptake by affecting diverse steps of insulin signaling in 3T3-L1 adipocytes It does this at multiple points in the pathway, not just one, which is part of why the effect can be robust. Research tracking hormone levels and insulin resistance across real menstrual cycles in healthy women has confirmed that progesterone is associated with increased insulin resistance.4PubMed Central. Longitudinal Study of Insulin Resistance and Sex Hormones over the Menstrual Cycle: The BioCycle Study
So the cycle creates a seesaw: estrogen-dominant phases tilt you toward better glucose handling, and progesterone-dominant phases tilt you toward mild insulin resistance. For most healthy people, the body compensates and you never notice. But when insulin regulation is already impaired, the tilt becomes harder to absorb.
Why This Matters Most for People With Type 1 Diabetes
The impact of the menstrual cycle on glucose is best documented in women with type 1 diabetes, where even small changes in insulin sensitivity translate to numbers you can see on a monitor. One study found that mean glucose rose from about 148 mg/dL during the early follicular phase to about 155 mg/dL during the late luteal phase.5PubMed. Changing Glucose Levels During the Menstrual Cycle as Observed in Adults in the Type 1 Diabetes Exercise Initiative Study That gap of about 7 mg/dL might sound trivial, but it reflects a shift in the entire glucose profile: more time spent above target, more highs, and more frustration when doses that worked last week seem to fall short.
Continuous glucose monitoring studies in women with type 1 diabetes have consistently found higher readings and more hyperglycemia during the second half of the cycle.6Diabetes Care. The Effect of the Menstrual Cycle on Glucose Control in Women With Type 1 Diabetes Evaluated Using a Continuous Glucose Monitoring System A separate study tracking insulin sensitivity across cycle phases found that the risk of hyperglycemia increased significantly through the early luteal phase and that insulin sensitivity was measurably depressed during the luteal phase compared to the early follicular phase.7PubMed Central. Fluctuations of Hyperglycemia and Insulin Sensitivity Are Linked to Menstrual Cycle Phases in Women With T1D
A systematic review pulling together this body of evidence concluded that in a subset of women with type 1 diabetes, the menstrual cycle has a real impact on glycemic control, specifically increased exposure to high blood sugar and decreased insulin sensitivity during the luteal phase.8PubMed Central. Menstrual Cycle, Glucose Control and Insulin Sensitivity in Type 1 Diabetes: A Systematic Review The word “subset” is important here. Not every woman with type 1 diabetes experiences a noticeable shift. But for those who do, the pattern can be predictable enough to plan around.
Research on people using automated insulin delivery systems has confirmed that insulin requirements, carbohydrate intake, and glucose outcomes all varied systematically across cycle phases, with total daily insulin and carb intake peaking during the luteal phase. The researchers estimated that insulin sensitivity was roughly 5% higher in the early follicular phase compared to the mid-luteal phase.9Diabetes Care. Effects of Menstrual Cycle on Insulin Sensitivity in Type 1 Diabetes: An Observational Study of Individuals Using an Automated Insulin Delivery System Time in range, the metric that captures how many hours per day glucose stays in the target zone, also declined from the early follicular to the late luteal phase across full menstrual cycles.10The Journal of Clinical Endocrinology & Metabolism. Ambulatory Glucose Profile According to Different Phases of the Menstrual Cycle in Women Living With Type 1 Diabetes
Are Cravings to Blame, or Is It the Hormones Themselves?
A reasonable assumption is that blood sugar goes up before your period because you eat more, especially carbs and sweets. The premenstrual craving phenomenon is real. One pilot study found a significant increase in food cravings during the luteal phase. But here is the interesting part: total calorie intake and the proportion of carbs, fat, and protein people ate did not actually change between cycle phases in that study, and no difference in insulin sensitivity was found in the small group measured.11PubMed Central. Insulin Sensitivity, Food Intake, and Cravings with Premenstrual Syndrome: A Pilot Study Cravings were there, but they did not always translate into eating differently.
The CGM study that tracked glucose across menstrual cycles accounted for self-reported food cravings, bloating, and fatigue in its analysis, and the glucose pattern still held.1PubMed Central. Blood glucose variance measured by continuous glucose monitors across the menstrual cycle This does not mean cravings never contribute. If you do eat significantly more sugar or carbohydrate-heavy food in the days before your period, that will obviously raise your glucose readings. But the hormonal shift itself appears to be the primary driver, not just a behavioral one.
Inflammation Adds Another Layer
Hormones are not the only thing fluctuating across the cycle. Markers of low-grade inflammation also shift. A study measuring C-reactive protein, a common inflammation marker, found that it changed significantly during the menstrual cycle, peaking during the early follicular phase. Inflammation tracked inversely with estrogen levels, and in women with more central body fat, inflammation correlated with greater insulin resistance.12The Journal of Clinical Endocrinology & Metabolism. Low-Grade Inflammation and Estimates of Insulin Resistance during the Menstrual Cycle in Lean and Overweight Women This means the relationship between your cycle and your blood sugar is not a simple two-hormone story. Inflammation, body composition, and stress hormones all interact with the estrogen-progesterone balance in ways that vary from person to person.
How Hormonal Contraceptives Change the Picture
If your natural hormones affect glucose handling, it makes sense that synthetic hormones would too. Research on combined oral contraceptives, the kind that contain both an estrogen and a progestin, has consistently found effects on glucose metabolism. A large study involving over 2,200 women found that glucose tolerance was altered in women using certain types of combined pills, particularly those containing nortestosterone-derived progestins and levonorgestrel. The strongest effect was seen in formulations with the highest estrogen doses. Contraceptives containing progesterone-derived progestins did not seem to alter glucose tolerance.13PubMed Central. The effects of hormonal contraceptives on glycemic regulation
The progestin type matters. Research comparing different oral contraceptive formulations found that levonorgestrel-containing pills had the greatest effect on glucose and insulin levels, followed by desogestrel and norethindrone. All three increased insulin resistance to a similar extent, though. Progestin-only formulations, interestingly, did not affect insulin resistance.14The Journal of Clinical Endocrinology & Metabolism. Insulin resistance, secretion, and metabolism in users of oral contraceptives
For most women, these effects are minor enough that the body compensates. But if you have type 1 or type 2 diabetes and you are starting or switching contraceptives, it is worth paying closer attention to your glucose readings for a few months to see whether your insulin needs change. And if you use continuous contraception that suppresses your natural cycle entirely, you may actually see more stable glucose readings than someone cycling naturally, because you are no longer getting the monthly rise and fall of progesterone.
PCOS and the Insulin Resistance Connection
Polycystic ovary syndrome adds a different dimension to this topic. PCOS is already closely tied to insulin resistance as a core feature of the condition, not just a side effect. Research on women with PCOS found that those with both high androgen levels and very irregular cycles (bleeding intervals of 45 days or more) had the most severe insulin resistance.15PubMed Central. Association between insulin resistance and abnormal menstrual cycle in Saudi females with polycystic ovary syndrome In other words, the relationship runs in both directions: hormonal imbalance worsens glucose handling, and insulin resistance can worsen hormonal imbalance.
If you have PCOS and irregular periods, the neat “follicular phase versus luteal phase” framework does not apply in the same way because your cycle may not follow the standard pattern. Your blood sugar challenges are more likely to be chronic and persistent rather than predictably rising and falling each month. This is one reason why lifestyle interventions and sometimes medication aimed at insulin sensitivity, rather than cycle-based dose adjustments, tend to be the focus for PCOS management.
Exercise and Fuel Use Shift Across the Cycle Too
The cycle does not just affect resting blood sugar. It also changes how your body uses fuel during exercise. A study comparing exercise metabolism in the follicular and luteal phases found that fat oxidation was significantly higher during the luteal phase at moderate exercise intensities.16PubMed. Glucose kinetics and substrate oxidation during exercise in the follicular and luteal phases This means your body preferentially burns more fat and relatively less carbohydrate for the same exercise effort in the second half of the cycle.
For casual exercisers, this is trivia. But for endurance athletes or anyone managing diabetes with exercise, it has real implications. If your body relies less on glucose during luteal-phase workouts, you might experience fewer exercise-related lows during that time, but also have less of a glucose-lowering effect from the same session. Someone who adjusts insulin for exercise might find they need slightly different strategies depending on where they are in their cycle. There is growing interest in “periodizing” training and nutrition around the menstrual cycle, though the evidence base is still thin on exactly how much individual athletes should adjust.
Practical Implications
If you do not have diabetes and are not tracking your glucose with a monitor, you are unlikely to notice any of this. The shifts in healthy individuals are within a narrow range, and the body’s regulatory machinery handles them quietly. You might feel different energy levels at various points in your cycle, and some of that may connect to these glucose dynamics, but nothing that requires medical action.
If you have type 1 diabetes and have ever noticed that your control seems worse in the week before your period, you are not imagining it. The evidence supports a real, hormone-driven shift in insulin sensitivity and glucose levels during the luteal phase. Some women find it helpful to increase their basal insulin by a small amount starting a few days before their period and dropping it back once bleeding starts. Others adjust their insulin-to-carb ratios. There is no one-size-fits-all number, but tracking your cycle alongside your glucose data for a few months can reveal your personal pattern.
If you have type 2 diabetes, the picture is muddier because less research has focused specifically on this population. The hormonal effects exist, but type 2 diabetes involves many other factors, like medication type, diet, body composition, and exercise, that can either amplify or mask the cycle’s contribution. Paying attention is still worthwhile, but the adjustments are less clear-cut than for type 1.
Why Researchers Took So Long to Study This
Given that roughly half the world’s population menstruates, it is striking how recent most of this research is. For decades, clinical trials in many fields routinely excluded women of childbearing age. A review of this practice found that the reasons boiled down to a lack of basic knowledge about female physiology and metabolism, which meant researchers viewed hormonal fluctuations as a confounding variable to be avoided rather than an important biological factor to study.17Europe PMC. Why researchers excluded women from their trial populations The result was a long stretch during which diabetes management guidelines were built overwhelmingly on data from men, and the menstrual cycle’s effects on blood sugar were left to individual patients to figure out on their own.
The expansion of continuous glucose monitoring has changed things rapidly. Before CGMs, studying glucose across a menstrual cycle required either frequent fingersticks, which are disruptive enough to change behavior, or inpatient glucose clamp studies, which are expensive and artificial. Wearable sensors that record glucose readings every few minutes for weeks at a time have given researchers the data density to see patterns that earlier study designs would have missed. Much of the strongest evidence cited in this article comes from the last ten years, and the field is moving quickly. Automated insulin delivery systems are beginning to incorporate cycle-phase data as one more variable to optimize around, though that technology is still in its early stages.